Recent News for ANIP - ANI Pharmaceuticals, Inc.

Date Title
Oct 12 Does ANI Pharmaceuticals (NASDAQ:ANIP) Deserve A Spot On Your Watchlist?
Oct 10 featured highlights include: Assurant, Opera, ANI, eXp and Avista
Oct 9 5 Stocks to Consider as New Analysts Initiate Coverage
Oct 3 ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study
Oct 2 ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg
Sep 29 Hedge Fund Mangrove Partners’ Top Stock Picks
Sep 13 FDA alerts on Zantac contamination
Sep 12 New coverage - healthcare
Sep 12 ANI Pharmaceuticals (NASDAQ:ANIP) Takes On Some Risk With Its Use Of Debt
Sep 11 ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL
Sep 6 Perrigo Prevacid deal stokes buying in generic players
Sep 5 Edited Transcript of ANIP earnings conference call or presentation 7-Aug-19 2:30pm GMT
Aug 28 Lanett's bullish outlook buoys generic players
Aug 14 Sanders after Teva and Mylan for "obstructing" pricing probe
Aug 13 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Delivered A Weaker ROE Than Its Industry
Aug 8 90 Biggest Movers From Yesterday
Aug 7 ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q2 2019 Results - Earnings Call Transcript
Aug 7 ANI Pharmaceuticals Inc (ANIP) Q2 2019 Earnings Call Transcript
Aug 7 ANI Pharma Q2 top-line up 15%; revenue guidance lowered
Aug 7 ANI Pharmaceuticals (ANIP) Q2 Earnings Surpass Estimates
Aug 7 ANI Pharmaceuticals EPS beats by $0.16, misses on revenue
Aug 7 ANI Pharmaceuticals Reports Second Quarter Results
Aug 7 The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Aug 6 ANI Pharmaceuticals Q2 2019 Earnings Preview
Jul 31 ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results
Back to the Main ANIP Page...